BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35151264)

  • 21. Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells.
    Qi Y; Wang N; He Y; Zhang J; Zou H; Zhang W; Gu W; Huang Y; Lian X; Hu J; Zhao J; Cui X; Pang L; Li F
    PLoS One; 2017; 12(8):e0182680. PubMed ID: 28829837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
    Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
    Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of SYT-SSX rearrangements in synovial sarcomas by real-time one-step RT-PCR.
    Nikiforova MN; Groen P; Mutema G; Nikiforov YE; Witte D
    Pediatr Dev Pathol; 2005; 8(2):162-7. PubMed ID: 15747098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma?
    Koković I; Bracko M; Golouh R; Ligtenberg M; van Krieken HJ; Hudler P; Komel R
    Cancer Detect Prev; 2004; 28(4):294-301. PubMed ID: 15350633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.
    Xie Y; Skytting B; Nilsson G; Grimer RJ; Mangham CD; Fisher C; Shipley J; Bjerkehagen B; Myklebost O; Larsson O
    Oncogene; 2002 Aug; 21(37):5791-6. PubMed ID: 12173050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha.
    Nagai M; Tanaka S; Tsuda M; Endo S; Kato H; Sonobe H; Minami A; Hiraga H; Nishihara H; Sawa H; Nagashima K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3843-8. PubMed ID: 11274403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synovial sarcoma. A Scandinavian Sarcoma Group project.
    Skytting B
    Acta Orthop Scand Suppl; 2000 Apr; 291():1-28. PubMed ID: 10862210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cells.
    Hayakawa K; Ikeya M; Fukuta M; Woltjen K; Tamaki S; Takahara N; Kato T; Sato S; Otsuka T; Toguchida J
    Biochem Biophys Res Commun; 2013 Mar; 432(4):713-9. PubMed ID: 23313505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors.
    Hiraga H; Nojima T; Abe S; Sawa H; Yamashiro K; Yamawaki S; Kaneda K; Nagashima K
    Diagn Mol Pathol; 1998 Apr; 7(2):102-10. PubMed ID: 9785009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of expression of cancer stem cell markers and fusion gene in synovial sarcoma: Insights into histogenesis and pathogenesis.
    Zhou Y; Chen D; Qi Y; Liu R; Li S; Zou H; Lan J; Ju X; Jiang J; Liang W; Shen Y; Pang L; Li F
    Oncol Rep; 2017 Jun; 37(6):3351-3360. PubMed ID: 28498445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel variant of SYT-SSX1 fusion gene in a case of spindle cell synovial sarcoma.
    Krsková L; Sumerauer D; Stejskalová E; Kodet R
    Diagn Mol Pathol; 2007 Sep; 16(3):179-83. PubMed ID: 17721327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1.
    Tsuda M; Watanabe T; Seki T; Kimura T; Sawa H; Minami A; Akagi T; Isobe K; Nagashima K; Tanaka S
    Oncogene; 2005 Dec; 24(54):7984-90. PubMed ID: 16103879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma.
    van de Rijn M; Barr FG; Collins MH; Xiong QB; Fisher C
    Am J Clin Pathol; 1999 Jul; 112(1):43-9. PubMed ID: 10396284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1.
    Sun Y; Gao D; Liu Y; Huang J; Lessnick S; Tanaka S
    Oncogene; 2006 Feb; 25(7):1042-52. PubMed ID: 16247461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma.
    Sun Y; Sun B; Wang J; Cai W; Zhao X; Zhang S; Hao X
    Cancer Sci; 2009 Jun; 100(6):1018-25. PubMed ID: 19385976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wulong Xiaozheng Wan medicated serum inhibits epithelial-mesenchymal transition in human gastric carcinoma cell line BGC823 by modulation of transforming growth factor-β1/Smad signaling.
    Zhang Y; Wang B; Yang L; Li D; Yuan X; Guo X
    J Tradit Chin Med; 2019 Jun; 39(3):380-392. PubMed ID: 32186010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.